Literature DB >> 2282339

Gender and short-term outcome in schizophrenia.

R K Salokangas1, E Stengård.   

Abstract

227 first-contact schizophrenic patients (DSM-III) were followed-up for 2 years. The psychiatric teams responsible for the treatment of the patients conducted a detailed, standardized interview with the patients at entry and during the follow-up. Men showed a poorer premorbid heterosexual development and they also tended to be more withdrawn than women. Following the onset of the illness, men still failed to establish satisfactory heterosexual relationships, they suffered more often from negative symptoms, and they displayed poorer working capacity and functional ability than women. At the beginning of the follow-up men had a more pessimistic view of the development of their life situation over the next 2 years, a prediction which turned out to be correct. The predictions made by the psychiatric teams were very similar. In their plans for treatment the psychiatric teams recommended primarily psychotherapeutic methods for female patients--and women actually went to psychotherapy more often than men--whereas it was felt that the rehabilitation of men should concentrate on working capacity and basic social skills. The poorer psychosocial outcome of men seems to be due to their poor premorbid development--specifically heterosexual development--and negative symptoms. Together, these factors form a particularly harmful combination from the point of view of the social role of men in our society. The treatment system seems to be unable to adequately respond to the specific needs of men suffering from schizophrenia.

Entities:  

Mesh:

Year:  1990        PMID: 2282339     DOI: 10.1016/0920-9964(90)90019-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  11 in total

1.  Symptom dimensions and outcome in schizophrenia.

Authors:  Raimo K R Salokangas
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

2.  The role of estrogen in schizophrenia.

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

3.  Stability and prediction of schizophrenia from adolescence to adulthood.

Authors:  Margareth I Helgeland; Svenn Torgersen
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-03       Impact factor: 4.785

4.  Marriage and gender in schizophrenia.

Authors:  R Thara; T N Srinivasan
Journal:  Indian J Psychiatry       Date:  1997-01       Impact factor: 1.759

5.  Gender differences in outcomes in people with schizophrenia in rural China: 14-year follow-up study.

Authors:  Mao-Sheng Ran; Wen-Jun Mao; Cecilia Lai-Wan Chan; Eric Yu-Hai Chen; Yeates Conwell
Journal:  Br J Psychiatry       Date:  2015-01-08       Impact factor: 9.319

6.  Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization.

Authors:  Helena Rantanen; Anna-Maija Koivisto; Raimo K R Salokangas; Mika Helminen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-28       Impact factor: 4.328

7.  First-contact rate for schizophrenia in community psychiatric care. Consideration of the oestrogen hypothesis.

Authors:  R K Salokangas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

8.  Needs of Patients with Schizophrenia Among an Ethnic Minority Group in Latin America.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Stephen E Gilman
Journal:  J Immigr Minor Health       Date:  2017-06

9.  Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up.

Authors:  Raimo K R Salokangas; Dorien H Nieman; Markus Heinimaa; Tanja Svirskis; Sinikka Luutonen; Tiina From; Heinrich Graf von Reventlow; Georg Juckel; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Frauke Schultze-Lutter; Joachim Klosterkötter; Stephan Ruhrmann
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-07-15       Impact factor: 4.328

10.  The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data.

Authors:  Mark Savill; Stavros Orfanos; Richard Bentall; Ulrich Reininghaus; Til Wykes; Stefan Priebe
Journal:  Psychiatry Res       Date:  2016-11-14       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.